Albemarle Corporation (ALB) Stock

About Albemarle Corporation

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Albemarle Corporation is led by CEO Jerry Kent Jr., employs 7,800 people, headquartered in Charlotte, US, publicly traded since 1994.

Albemarle Corporation (ALB) stock trades at $113.35 with a market capitalization of $13.37B. The stock is valued at a price-to-earnings (P/E) ratio of -33.78, price-to-book of 2.40, price-to-sales of 3.97. Over the past 52 weeks the stock has ranged between $53.70 and $215.71, and currently trades 47.5% below its 52-week high. It pays a dividend yielding 0.80%.

On profitability, Albemarle Corporation generates a return on equity (ROE) of -5.36%, return on capital employed of 0.96%, an operating margin of 1.83%, a net profit margin of -4.24%.

Official website: www.albemarle.com